Effects of Nigella sativa and its constituents on total white blood cells count and airway responsiveness value in ovalbumin-induced asthma models: A preclinical systematic review and meta-analysis
محل انتشار: مجله گیاهان دارویی ابن سینا، دوره: 15، شماره: 6
سال انتشار: 1404
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 154
فایل این مقاله در 27 صفحه با فرمت PDF قابل دریافت می باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_AJP-15-6_004
تاریخ نمایه سازی: 25 مهر 1404
چکیده مقاله:
Objective: Evidence indicates that Nigella sativa (NS) and its key compounds such as carvacrol, thymoquinone, thymol, and α-hederin exhibit properties that reduce inflammation, act as antioxidants, and modulate the immune system. This meta-analysis investigated the preclinical evidence of NS reported in animal models of ovalbumin (OVA)-induced asthma.Materials and Methods: Studies done on NS and its components in animal models of OVA-induced asthma in all published articles up to July ۲۰۲۴ were searched in Scopus, PubMed, and Web of Science databases. The studies underwent assessment of methodological quality utilizing the ۱۵-point CAMARADES checklist. MedCalc software was utilized for performing the data analysis.Results: Sixteen studies involving a total of ۴۸۶ animals, with ۲۴۳ in the intervention group and ۲۴۳ in the ovalbumin-induced group were analyzed. In the meta-analysis results, it was shown that NS and its components notably decreased total white blood cells (WBC), eosinophils, lymphocytes, and neutrophils. Additionally, NS caused a shift in the half of the maximum effective concentration (EC۵۰) curve to the right and decreased the maximum response rates and tracheal OVA-response in experimental animals.Conclusion: NS, and its components, could potentially influence asthma induced by OVA in animals by improving airway responsiveness and exhibiting anti-inflammatory and anti-oxidant properties. Consequently, it is recommended that NS be evaluated in additional clinical trials for patients with asthma.
کلیدواژه ها:
نویسندگان
Elmira Mohammadzadeh
Ardabil University of Medical Sciences Ardabil Iran
Hassan Ghobadi
Ardabil University of Medical Sciences Ardabil Iran
Jafar Mohammadshahi
Ardabil University of Medical Sciences Ardabil Iran
Farzin Aslani
Ardabil University of Medical Sciences Ardabil Iran
Mohammad Hossein Boskabady
Physiology
Mohammad Reza Aslani
Department of physiology, Ardabil university of medical sciences